Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Pubmed

Three-dimensional visualization of testis cord morphogenesis, a novel tubulogenic mechanism in development.

NPHP1 COL5A2 SEMA5A FAM53A

1.69e-0619616419334288
Pubmed

DEAD-box helicase DDX27 regulates 3' end formation of ribosomal 47S RNA and stably associates with the PeBoW-complex.

CHAMP1 SYT10

1.46e-043916225825154
CytobandEnsembl 112 genes in cytogenetic band chr8q24

CYP11B1 MTSS1

6.66e-03355162chr8q24
ToppCellNS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NPHP1 SYT10 PROSER3 SEMA5A

5.39e-07190164250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SYT10 PLEKHA2 SEMA5A

2.13e-0515416312cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCellHealthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

SYT10 ATP8B2 MTSS1

3.12e-05175163eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCellHealthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass

SYT10 ATP8B2 MTSS1

3.12e-05175163ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

3.92e-05189163a153b83314cf52808f685296cff8c95af3f4983d
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

3.92e-05189163e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

3.92e-051891632a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellFibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

PLEKHA2 SEMA5A MTSS1

3.99e-05190163b4088128f5acf53f43244c9af9fe44e033f1a57a
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

3.99e-05190163841cd55861b43578d704418b9bc0af2e8b88323a
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

3.99e-05190163d60395739458d7f47a3350ade751fe3819500320
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.05e-05191163b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-05192163dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-05192163162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-051921636f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-05192163f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-051921633d0cb19f037f604253d7d728689aeaa94251e92b
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-05192163df1545670370fb1010c567cd059c2783eab315f7
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-05192163deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.11e-05192163ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.18e-05193163fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

COL5A2 SYT10 SEMA5A

4.18e-05193163084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.24e-0519416360622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

COL5A2 SEMA5A DLGAP1

4.24e-05194163e93de9428c986b8943fc169258847c650cfab0e5
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.24e-051941636e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL5A2 SEMA5A DLGAP1

4.24e-0519416389b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellmoderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

NPHP1 SYT10 SEMA5A

4.24e-051941635dffa578149104dda33774361e9e77b227b5f1ce
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 SEMA5A DLGAP1

4.31e-05195163d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCellParenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

COL5A2 PLEKHA2 SEMA5A

4.44e-0519716341dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCellParenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

COL5A2 PLEKHA2 SEMA5A

4.44e-05197163f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL5A2 SEMA5A KIAA1549L

4.44e-05197163c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL5A2 SEMA5A KIAA1549L

4.64e-05200163ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

COL5A2 MTSS1

5.84e-0532162ba89b22a5ce8ee9f3099b1fa84721724b94c7759
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

COL5A2 MTSS1

5.84e-053216258b212d4f2955f06a195df0f79ad95a8ff145b83
ToppCellMild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

PLEKHA2 ICE2

8.40e-0412116268940a552233d255b90ce5a081339c0d9d46ab02
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SYT10 PLEKHA2

9.68e-0413016256b9c3325e011f1dbaf9efc71bd6e1af4f96fda6
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PLEKHA2 ICE2

9.83e-04131162a3a086ce6e69707ca6a042f3b15c130f81909acb
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-6|TCGA-Thryoid / Sample_Type by Project: Shred V9

DLGAP1 MTSS1

9.98e-04132162b7611c6a5c86908132e7ab3e41d67277e8142db1
ToppCellStriatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32

COL5A2 PROSER3

1.03e-03134162a3547a68012d879d4dfe80394eace70808722e43
ToppCellStriatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32

COL5A2 PROSER3

1.03e-031341629458e2d0dbc18d9025b66b59f3ecc2fbc5384940
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DLGAP1 ATP8B2

1.12e-031401629f105687f5749399fd76043fd85da58be30f2caf
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DLGAP1 ATP8B2

1.12e-03140162a3be1fb7d2eb44bc123456d03250502938d46d9d
ToppCellSevere-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NPHP1 MTSS1

1.15e-03142162f9cbc266fcea19bec504be4f3a28d1173c6b2e3c
ToppCellsevere_COVID-19-Treg|World / disease group, cell group and cell class (v2)

C8orf44 DLGAP1

1.15e-03142162cccc2e738eeca342cd937c4cd863571951b2257e
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

COL5A2 DLGAP1

1.19e-031441621c001a5a3bbe4ecbce8305f8b260e933033550dd
ToppCellmild_COVID-19_(asymptomatic)-Treg|World / disease group, cell group and cell class (v2)

DLGAP1 ATP8B2

1.20e-03145162a3b0e1d0ce0caa8b281a146439d6455db64cc3e5
ToppCellmild_COVID-19_(asymptomatic)-Treg|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

DLGAP1 ATP8B2

1.20e-031451622d0903009e918500facfd017ff31f2cec1e76131
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Tgfb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

COL5A2 PLEKHA2

1.20e-0314516284d50a13b48d50c16e768422908e371a55972d0e
ToppCellCOVID-19_Mild-PLT_3|World / Disease Group and Platelet Clusters

DLGAP1 MINAR1

1.23e-031471629d3271aa735ddb6f32ab864d7afcfb0f8754383b
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CHAMP1 ATP8B2

1.27e-0314916265778f19599b4955c0a16f0121237656449431fb
ToppCellPericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

COL5A2 SEMA5A

1.28e-03150162dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NPHP1 MTSS1

1.28e-031501624bdcdce40f54580c7a4e1416b468e657ba8874fc
ToppCellInt-URO-Other|Int-URO / Disease, Lineage and Cell Type

NPHP1 SEMA5A

1.30e-03151162ea5f25842e621be41a6491c9959d419d9cc7ebd6
ToppCellInt-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type

NPHP1 SEMA5A

1.30e-031511620344d482f1c55c9eaa15beb8d6bac1c6cdca21b3
ToppCellmild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2)

NPHP1 PROSER3

1.32e-03152162f944743f40ff6ed3a7a096dd53e12d3526c67c4d
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SEMA5A MTSS1

1.34e-031531629c6fce56300ba5053efda59a438d63a808c497c0
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MTSS1 KIAA1549L

1.35e-03154162617ad0929d2ac0eeb7b8d9b0cba687176e684ed0
ToppCellmild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

NPHP1 PROSER3

1.37e-03155162e2c901d5c9e42d25d7702e5e8fc19b06f7c817be
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SYT10 SEMA5A

1.39e-03156162fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCell5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLEKHA2 KIAA1549L

1.39e-03156162203ef22eb76bd2b829b027c30af0557080f4006c
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9

COL5A2 MINAR1

1.39e-0315616245a05c7a45a3ec8551818ab67f18b3b9553934c1
ToppCellNS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NPHP1 SYT10

1.41e-03157162410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MTSS1 KIAA1549L

1.41e-0315716210341ed8cbee0f636770a82cf580f6453bee8596
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

COL5A2 PLEKHA2

1.42e-031581629e0589f770920f8ac41cfe5cd0a29e9e7a04a308
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 MTSS1

1.44e-031591625ca96db4281abb5f646150ccf36adc66ab201c78
ToppCellHealthy/Control-Treg|Healthy/Control / Disease group and Cell class

DLGAP1 ATP8B2

1.44e-0315916216a322760c99f3e2c3b73cbb399f77868951d3cb
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 SYT10

1.46e-0316016214dfa519e68bab4bce890ddb66fa7763f18d9f19
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 SYT10

1.46e-031601625b7789d4668ed7732babedc32d812233b430e0bd
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL5A2 KIAA1549L

1.46e-03160162c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL5A2 KIAA1549L

1.46e-0316016225c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 SYT10

1.46e-03160162bba1486faaad5299e10f4fe17c6d149c28dc2560
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP1 KIAA1549L

1.46e-03160162f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 SYT10

1.46e-03160162839bbdfd4e4c7b48260c8bfb7670378634405e1d
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DLGAP1 ATP8B2

1.48e-03161162b24293fdae9637983fcf4f2d4659a3554e00a53f
ToppCellHealthy/Control-Treg|World / Disease group and Cell class

DLGAP1 ATP8B2

1.48e-03161162457297cda5c9cee3bcc069fdecbbe24def027e5f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ATP8B2 MINAR1

1.48e-03161162a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DLGAP1 ATP8B2

1.48e-03161162eddcbe266d4a84a340fa8f2128d2b7e293968dca
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ATP8B2 MINAR1

1.48e-0316116208920a716f6ec62538e361211455a30ad726d7be
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

COL5A2 PLEKHA2

1.50e-031621622d28306c6125b31f11ea6d911a167b93a74907c5
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_LINC00507_SLN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL5A2 SYT10

1.50e-03162162b59a0081e285cdf33de56e8b523fe0e446a198f1
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DLGAP1 MTSS1

1.50e-0316216280619a93c57fe16daf91dc571874ef9ac888953d
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SEMA5A MTSS1

1.51e-03163162ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8
ToppCellHealthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass

ATP8B2 MTSS1

1.51e-031631622913ccdd4613472cd82077d4993e1d9f8b223398
ToppCellHealthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

ATP8B2 MTSS1

1.51e-03163162b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

COL5A2 FAM53A

1.53e-031641629b4a6007abae992db871d9f6f731d5af724de30d
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_PSRC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL5A2 SYT10

1.55e-031651626de69b75174731931e7e80a3488f983a7ba4defe
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

COL5A2 SYT10

1.55e-0316516200c1d9fce3a017d05ec02133e56be371ab2148f1
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SEMA5A MTSS1

1.59e-031671621c1b4722c6c0eff85a9b32ca7b4e281caebf63b0
ToppCellmild-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PLEKHA2 MTSS1

1.59e-031671620811f7559c2a7151693771e52e14af3978997118
ToppCellmild_COVID-19-Treg|World / disease group, cell group and cell class (v2)

DLGAP1 ATP8B2

1.59e-0316716269330689b6e353c8ee9ea1b63a5eac6ab38d456f
ToppCellCOVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class

DLGAP1 ATP8B2

1.59e-031671624ddb21421cbe72c06b61dd3a5eb1337e59de42e5
ToppCellCOVID-19_Moderate-Treg|World / disease group, cell group and cell class

DLGAP1 ATP8B2

1.63e-0316916227ad11239559b025bef582f89b2a83501d9d3993
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL5A2 KIAA1549L

1.63e-03169162031465190cd3623a25ef2b868daab8d932c8ff08
ToppCellNS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NPHP1 SYT10

1.64e-03170162f6a0162bb690dbc19ff1cec64cb933744ad3b496
ToppCellCV-Mild-7|CV / Virus stimulation, Condition and Cluster

NPHP1 ICE2

1.64e-0317016225ebde7d2f8ae1afdfaf5876284ff20bb179eb10
ToppCelldroplet-Kidney-nan-21m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP1 ATP8B2

1.64e-03170162510625bd725d3590cffcd7acd1d42219f6eb1139
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL5A2 MINAR1

1.66e-03171162b0373ed8283ee1792b6a490bff93906546978593
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SYT10 PLEKHA2

1.66e-03171162d07e2c5f7d7f12c68860d4161d76372de174f1d8
ToppCellControl-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations)

COL5A2 SEMA5A

1.66e-03171162080003f698f867935c2bfc55d241d3650f45a0ab
ToppCellPericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

COL5A2 KIAA1549L

1.66e-03171162bbc8d9fc83d37c9250345b1e76776610799de9ae
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL5A2 KIAA1549L

1.66e-0317116215cb4670ff4234ac46aea8a5911138d6913c4482
DrugMaprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A

NPHP1 COL5A2 ATP8B2 MTSS1

8.24e-061921643236_UP
Diseasecomplement factor H-related protein 1 measurement

CYP11B1 KIAA1549L

4.17e-0456162EFO_0600054
Diseasetestosterone measurement

CHAMP1 DLGAP1 CYP11B1 ICE2 MINAR1

4.38e-041275165EFO_0004908
DiseaseParkinson disease

COL5A2 SYT10 SEMA5A

6.43e-04321163MONDO_0005180
Diseaseosteoarthritis

FAM53A MINAR1

6.31e-03222162MONDO_0005178

Protein segments in the cluster

PeptideGeneStartEntry
SPEVRSSKPAWPTWR

C8orf44

56

Q96CB5
SSKPAWPTWRNPIFT

C8orf44

61

Q96CB5
PKARPSTSPGWWSSD

DLGAP1

191

O14490
WARAQAPPSWSRKKP

ATP8B2

11

P98198
APPSWSRKKPSWGTE

ATP8B2

16

P98198
FPSSQIPSWKDWAKP

MTSS1

401

O43312
PNLLSTSWTFPRWKK

KIAA1549L

251

Q6ZVL6
SWPKSGWPSAFQKPK

ICE2

691

Q659A1
RPWKSNPSASSGPWK

CHAMP1

321

Q96JM3
SPSSWKSPPASPESW

CHAMP1

376

Q96JM3
PRSLSRWTSPKVWKE

CYP11B1

241

P15538
PSSVPRKTWWASKSP

COL5A2

1341

P05997
ATWQPKKPKTWTFSP

NPHP1

426

O15259
GKPNKQTPWPAKSWS

MINAR1

356

Q9UPX6
KAPSVASSWQPWTPV

PLEKHA2

346

Q9HB19
WPSQSQTWCPKTLSP

PROSER3

26

Q2NL68
KTTPWTPWTPVNISD

SEMA5A

706

Q13591
WPCWKSKPVTSNITT

SYT10

81

Q6XYQ8
PWRPGSSKVWTPVSK

FAM53A

136

Q6NSI3